Siemens Healthcare Laboratory is the exclusive provider of the noninvasive Enhanced Liver Fibrosis (ELF™) testing* service for all stages of clinical trials in the United States. The ELF test* is a blood test performed in our CLIA laboratory. It is currently used in several early- and late-stage clinical trials for metabolic diseases, including primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH), hepatitis C, and hepatitis B therapies.
In addition, a full range of routine diagnostic tests for liver-related conditions is available upon request. As an integrated diagnostics company, we also offer access to our expertise in the use of ultrasound and magnetic resonance (MR) for noninvasive management of patients with liver fibrosis.
*The Enhanced Liver Fibrosis (ELF™) testing service is exclusively performed in the US by Siemens Healthcare CLIA Laboratory, Berkeley, California.
Siemens Healthcare Laboratory has an active program developing cerebral spinal fluid and blood biomarkers for a variety of neurodegenerative conditions.
Digital and image-based biomarkers may also revolutionize the management of neurological conditions. Our diagnostic imaging teams currently support a number of groundbreaking projects to help accurately diagnose Multiple Sclerosis and Alzheimer’s Disease for use in clinical trials and beyond.
Gene Therapy Development Services
Siemens Healthcare Laboratory specializes in developing molecular shedding, cell-based infectivity, and detection of viral antibodies using immunoassays for gene-therapy development needs.
At the cutting edge of medicine, viruses have been engineered into serving as therapy platforms to infect and deploy genetic material to correct deleterious genetic mutations in specific target tissues.
Diagnostics are critical in identifying patients with rare diseases. Our expertise with molecular and serological protein tests, combined with our biomarker assay development and testing services via our CLIA laboratory, can help to make diagnostic solutions affordable for your rare-disease therapies.
SHL offers solid tumor, single cell, liquid biopsy, and whole exome next-generation sequencing (NGS) services for comprehensive gene alteration and variant analysis for all stages of clinical trials.
As an integrated diagnostics company, we also offer expertise on the use of ultrasound and magnetic resonance (MR) for management of patients with cancer.
Siemens Healthcare Laboratory has expertise in retrovirus (hepatitis C and HIV) sequencing using Sanger and NGS technologies for comprehensive results.
Siemens Healthineers is a leading supplier of molecular tests and antibody tests for HIV and hepatitis C and B viruses.